Skip to content

Expensify, Inc. EXFY Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Navan, Inc.
 logo
Navan, Inc. NAVN
Priority Technology Holdings logo
Priority Technology HoldingsPRTH
Freshworks, Inc. logo
Freshworks, Inc.FRSH
Pathward Financial, Inc. logo
Pathward Financial, Inc.CASH
Paylocity logo
PaylocityPCTY
International Money Express logo
International Money ExpressIMXI

Other financials

Income statement

See full
Revenue$34.0M-5.8%
Gross profit$16.2M-11.4%
Operating income-$2.0M-32.6%
Net income-$2.3M+26.3%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$109.6M+13.8%
Total debt$678.0K-18.2%
Total equity$138.5M+2.9%
Total assets$190.6M+0.7%

Cash flow

See full
Operating cash flow$118.0K-98.5%
CapEx$182.0K+4.6%
Free cash flow-$64.0K-101%

Valuation

See full
Market cap$172.62M-24.4%
P/S1.2×-0.3×

Profitability

See full
Gross margin49.6%-2.8pp
Operating margin-13.2%
Net margin-14.7%-86.5pp
FCF margin8.8%-11.0pp

Returns & leverage

See full
Return on equity-15.1%+177pp
Debt / equity0.0×
Current ratio3.5×+0.2×

Where this comes from

Reported directly by Expensify, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Expensify, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Expensify, Inc.'s preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Expensify, Inc.'s preferred stock, shares authorized?
Expensify, Inc. (EXFY) reported preferred stock, shares authorized of $10M in Q1 2026.
How has Expensify, Inc.'s preferred stock, shares authorized changed year-over-year?
Expensify, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
What is the long-term trend for Expensify, Inc.'s preferred stock, shares authorized?
Over 4 years (2021 to 2025), Expensify, Inc.'s preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.